Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
88.80
+1.79 (2.06%)
Mar 13, 2026, 4:00 PM EDT - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts that cover Nutex Health stock have a consensus rating of "Strong Buy" and an average price target of $252.5, which forecasts a 184.35% increase in the stock price over the next year. The lowest target is $205 and the highest is $300.
Price Target: $252.5 (+184.35%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 26, 2025.
Analyst Ratings
The average analyst rating for Nutex Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $225 → $205 | Strong Buy | Maintains | $225 → $205 | +130.86% | Aug 26, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $300 | Strong Buy | Reiterates | $300 | +237.84% | Jul 10, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $225 | Strong Buy | Maintains | $100 → $225 | +153.38% | May 20, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $150 → $300 | Strong Buy | Maintains | $150 → $300 | +237.84% | May 15, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $60 → $150 | Strong Buy | Maintains | $60 → $150 | +68.92% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
1.04B
from 875.26M
Increased by 18.71%
Revenue Next Year
1.07B
from 1.04B
Increased by 2.79%
EPS This Year
21.42
from 10.48
Increased by 104.39%
EPS Next Year
26.46
from 21.42
Increased by 23.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.1B | 1.1B |
| Avg | 1.0B | 1.1B |
| Low | 973.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 25.4% | 5.8% |
| Avg | 18.7% | 2.8% |
| Low | 11.2% | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 22.85 | 27.24 |
| Avg | 21.42 | 26.46 |
| Low | 19.17 | 25.42 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 118.0% | 27.2% |
| Avg | 104.4% | 23.5% |
| Low | 82.9% | 18.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.